BioPartners GmbH Signs 10 Year License and Supply Agreement With The Medical House for Needle-Free Delivery System for Human Growth Hormone.
PR Newswire Europe, February, 2005
ZUG, Switzerland, February 22 /PRNewswire/ -- BioPartners, a global biopharmaceuticals company and one of the leaders in the emerging field of competitively priced biosimilar products and The Medical House PLC ("TMH"), (AIM:MLH) the orthopaedic devices and drug delivery company are pleased to announce a 10 year agreement for license and supply of TMH's GH1 reusable, spring-powered, needle-free delivery system for the delivery of BioPartners' recombinant human growth hormone product, Valtropin(tm) (somatropin).
The agreement is on an exclusive world-wide basis and ...
Most Recent Business Articles
- How do I determine my retainer fee?
- Why fly solo when an executive assistant can accelerate your CLNC® business?
- The CLNC® mentors held the key to my first case and to my CLNC® success
- Atlanta CLNC® 6-day certification seminar photo gallery—plus sign up today for spring 2009 to save $100.00
- Speak to a full-time practicing CLNC® consultant
Most Recent Business Publications
Most Popular Business Articles
- Using object-oriented analysis and design over traditional structured analysis and design
- Big Fish Games Migrates Upstream to Fisher Plaza; High Growth Online Gaming Firm Vaults Fisher Plaza Occupancy Rate Above 90%
- Top of the line: some of the world's most well-respected doctors practice in South Florida. A guide to choosing the best physician specialists - Top Doctors in South Florida
- Sand filter basics: high-rate sand filters can be confusing for those new to the business. Understanding valve modes is the key
- BEHR Paints Introduces a Colorful New Way to Paint and Prime All in One with BEHR Premium Plus Ultra™ Interior
Sponsored by Merrill Lynch